Toll Free: 1-888-928-9744
Published: Jul, 2016 | Pages:
43 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
RaQualia Pharma Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'RaQualia Pharma Inc. - Product Pipeline Review - 2016', provides an overview of the RaQualia Pharma Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by RaQualia Pharma Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of RaQualia Pharma Inc. - The report provides overview of RaQualia Pharma Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses RaQualia Pharma Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features RaQualia Pharma Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate RaQualia Pharma Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for RaQualia Pharma Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding RaQualia Pharma Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 RaQualia Pharma Inc. Snapshot 5 RaQualia Pharma Inc. Overview 5 Key Information 5 Key Facts 5 RaQualia Pharma Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 RaQualia Pharma Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 RaQualia Pharma Inc. - Pipeline Products Glance 11 RaQualia Pharma Inc. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 RaQualia Pharma Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 RaQualia Pharma Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 RaQualia Pharma Inc. - Drug Profiles 15 tegoprazan 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RQ-00000010 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RQ-00310941 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RQ-00000774 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 RQ-00201894 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 RQ-00202730 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 RQ-00203066 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 RQ-00203078 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 RQ-00433412 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecule to Block Cav3.2 for Neuropathic Pain 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecules to Block Nav1.7 Sodium Channel for Pain 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecules to Block Nav1.8 Sodium Channel for Pain 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 RQ-00434739 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecule for Pain 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule for Undisclosed Indication 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 RaQualia Pharma Inc. - Pipeline Analysis 30 RaQualia Pharma Inc. - Pipeline Products by Target 30 RaQualia Pharma Inc. - Pipeline Products by Route of Administration 32 RaQualia Pharma Inc. - Pipeline Products by Molecule Type 33 RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action 34 RaQualia Pharma Inc. - Recent Pipeline Updates 36 RaQualia Pharma Inc. - Dormant Projects 40 RaQualia Pharma Inc. - Locations And Subsidiaries 41 Head Office 41 Other Locations & Subsidiaries 41 Appendix 42 Methodology 42 Coverage 42 Secondary Research 42 Primary Research 42 Expert Panel Validation 42 Contact Us 42 Disclaimer 43
List of Tables
RaQualia Pharma Inc., Key Information 5 RaQualia Pharma Inc., Key Facts 5 RaQualia Pharma Inc. - Pipeline by Indication, 2016 8 RaQualia Pharma Inc. - Pipeline by Stage of Development, 2016 9 RaQualia Pharma Inc. - Monotherapy Products in Pipeline, 2016 10 RaQualia Pharma Inc. - Phase III, 2016 11 RaQualia Pharma Inc. - Phase I, 2016 12 RaQualia Pharma Inc. - Preclinical, 2016 13 RaQualia Pharma Inc. - Discovery, 2016 14 RaQualia Pharma Inc. - Pipeline by Target, 2016 31 RaQualia Pharma Inc. - Pipeline by Route of Administration, 2016 32 RaQualia Pharma Inc. - Pipeline by Molecule Type, 2016 33 RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action, 2016 35 RaQualia Pharma Inc. - Recent Pipeline Updates, 2016 36 RaQualia Pharma Inc. - Dormant Developmental Projects,2016 40 RaQualia Pharma Inc., Other Locations 41 RaQualia Pharma Inc., Subsidiaries 41
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.